Brimonidine-tartrate-UK-14304-tartrate-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Brimonidine-tartrate-UK-14304-tartrate-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Brimonidine-tartrate-UK-14304-tartrate-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBrimonidine tartrateCat. No.: HY-B0659ACAS No.: 70359-46-5Synonyms: UK 14304 (tartrate); AGN190342 (tartrate)分式: CHBrNO分量: 442.22作靶點(diǎn): Adrenergic Receptor作通路: GPCR/G Protein; Neuronal Signaling儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn

2、 solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 37 mg/mL (83.67 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.2613 mL 11.3066 mL 22.6132 mL5 mM 0.4523 mL 2.2613 mL 4.5226 mL10 mM 0.2261 mL 1.1307 mL 2.2613 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存

3、式和期限。BIOLOGICAL ACTIVITY物活性 Brimonidine tartrate (UK 14304 tartrate)是_alpha_2-adrenergic receptor (_alpha_2-AR)受體激動(dòng)劑。IC50 & Target 2-adrenergic Receptor 1.體外研究3HBrimonidine (UK 14304) is a full agonist at alpha 2-adrenergic receptors. 3HBrimonidine (UK 14304)1/2 Master of Small Molecules 您邊的抑制劑師www.

4、MedChemElabels at least 2 specific binding sites in human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies ateach site 1-3.REFERENCES1. Andorn, A.C., M.A. Carlson, and R.C. Gilkeson, Spe

5、cific 3HUK 14,304 binding in human cortex occurs at multiple high affinity stateswith alpha 2-adrenergic selectivity and differing affinities for GTP. Life Sci, 1988. 43(22): p. 1805-12.2. Cambridge, D., UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor

6、subtypes. Eur JPharmacol, 1981. 72(4): p. 413-5.3. Chopin, P., F.C. Colpaert, and M. Marien, Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats withunilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther, 1999. 288(2): p. 798-804.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.Tel: 40

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論